SPECIALTY RX STRATEGIES
Pharmacy represents 25% to 35% of the overall expense on healthcare and is expected to increase at a rate of 5% to 10% each year for the foreseeable future. Specialty drug spend is expected to see more than a 3% price inflation in the upcoming years.
The bio-specialty drug category accounts for 35% to 55% of total pharmacy spend on average in the US and is expected to increase to 60% even though only 1% to 3% of Americans use specialty drugs.
60% of Americans live with a chronic illness, and account for 91% of all prescriptions filled. In addition, health care coverage costs for individuals managing a chronic condition is 5X higher than those without a condition.
At the time of the COVID-19 outbreak, the use of telehealth services was expected to grow by 80% in 2020 alone and forecasted to expand at a rate of 29% by
The Enhanced Care Management Program (ECMP) is a plug-and-play, chronic care support program developed and managed by Pharma Strategies, LLC. This proven and confirmed methodology can be easily added to almost any existing self-insured arrangement to improve medical outcomes and significantly lower pharmaceutical expense. The program is provided at no administrative cost to the employer or insured and is designed to be implemented with minimal administrative impact.
The Pharma Strategies ECMP incorporates existing community health provider networks and their associated drug discounts to provide employees with improved care coordination and employers with better long-term claims results and substantially lower RX prices.